nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—Acidosis—Metformin—metabolic syndrome X	0.0575	0.0606	CcSEcCtD
Levobupivacaine—Body temperature decreased—Metformin—metabolic syndrome X	0.0567	0.0598	CcSEcCtD
Levobupivacaine—Hypothermia—Metformin—metabolic syndrome X	0.0567	0.0598	CcSEcCtD
Levobupivacaine—Fungal infection—Metformin—metabolic syndrome X	0.0412	0.0434	CcSEcCtD
Levobupivacaine—Rigors—Metformin—metabolic syndrome X	0.039	0.0411	CcSEcCtD
Levobupivacaine—Neuropathy—Metformin—metabolic syndrome X	0.0299	0.0315	CcSEcCtD
Levobupivacaine—Lightheadedness—Metformin—metabolic syndrome X	0.0285	0.03	CcSEcCtD
Levobupivacaine—Injury—Metformin—metabolic syndrome X	0.0251	0.0265	CcSEcCtD
Levobupivacaine—Lethargy—Metformin—metabolic syndrome X	0.0236	0.0248	CcSEcCtD
Levobupivacaine—Abdominal distension—Metformin—metabolic syndrome X	0.0201	0.0212	CcSEcCtD
Levobupivacaine—Sweating increased—Metformin—metabolic syndrome X	0.0194	0.0205	CcSEcCtD
Levobupivacaine—Drowsiness—Metformin—metabolic syndrome X	0.0178	0.0188	CcSEcCtD
Levobupivacaine—Infestation NOS—Metformin—metabolic syndrome X	0.0178	0.0188	CcSEcCtD
Levobupivacaine—Infestation—Metformin—metabolic syndrome X	0.0178	0.0188	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Metformin—metabolic syndrome X	0.0174	0.0184	CcSEcCtD
Levobupivacaine—Bradycardia—Metformin—metabolic syndrome X	0.0163	0.0171	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Metformin—metabolic syndrome X	0.0159	0.0168	CcSEcCtD
Levobupivacaine—Oedema peripheral—Metformin—metabolic syndrome X	0.0157	0.0166	CcSEcCtD
Levobupivacaine—Flushing—Metformin—metabolic syndrome X	0.0148	0.0156	CcSEcCtD
Levobupivacaine—Cardiac disorder—Metformin—metabolic syndrome X	0.0148	0.0156	CcSEcCtD
Levobupivacaine—Chills—Metformin—metabolic syndrome X	0.0143	0.0151	CcSEcCtD
Levobupivacaine—Erythema—Metformin—metabolic syndrome X	0.0139	0.0147	CcSEcCtD
Levobupivacaine—Malnutrition—Metformin—metabolic syndrome X	0.0139	0.0147	CcSEcCtD
Levobupivacaine—Flatulence—Metformin—metabolic syndrome X	0.0137	0.0144	CcSEcCtD
Levobupivacaine—Muscle spasms—Metformin—metabolic syndrome X	0.0134	0.0141	CcSEcCtD
Levobupivacaine—Vision blurred—Metformin—metabolic syndrome X	0.0131	0.0138	CcSEcCtD
Levobupivacaine—Tremor—Metformin—metabolic syndrome X	0.013	0.0137	CcSEcCtD
Levobupivacaine—Syncope—Metformin—metabolic syndrome X	0.0125	0.0131	CcSEcCtD
Levobupivacaine—Palpitations—Metformin—metabolic syndrome X	0.0123	0.013	CcSEcCtD
Levobupivacaine—Loss of consciousness—Metformin—metabolic syndrome X	0.0122	0.0129	CcSEcCtD
Levobupivacaine—Hypertension—Metformin—metabolic syndrome X	0.012	0.0127	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.0118	0.0124	CcSEcCtD
Levobupivacaine—Oedema—Metformin—metabolic syndrome X	0.0113	0.012	CcSEcCtD
Levobupivacaine—Infection—Metformin—metabolic syndrome X	0.0113	0.0119	CcSEcCtD
Levobupivacaine—Shock—Metformin—metabolic syndrome X	0.0112	0.0118	CcSEcCtD
Levobupivacaine—Nervous system disorder—Metformin—metabolic syndrome X	0.0111	0.0117	CcSEcCtD
Levobupivacaine—Skin disorder—Metformin—metabolic syndrome X	0.011	0.0116	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Metformin—metabolic syndrome X	0.011	0.0116	CcSEcCtD
Levobupivacaine—Hypotension—Metformin—metabolic syndrome X	0.0106	0.0112	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.0103	0.0109	CcSEcCtD
Levobupivacaine—Paraesthesia—Metformin—metabolic syndrome X	0.0102	0.0107	CcSEcCtD
Levobupivacaine—Dyspnoea—Metformin—metabolic syndrome X	0.0101	0.0107	CcSEcCtD
Levobupivacaine—Somnolence—Metformin—metabolic syndrome X	0.0101	0.0106	CcSEcCtD
Levobupivacaine—Dyspepsia—Metformin—metabolic syndrome X	0.00999	0.0105	CcSEcCtD
Levobupivacaine—Decreased appetite—Metformin—metabolic syndrome X	0.00987	0.0104	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.0098	0.0103	CcSEcCtD
Levobupivacaine—Constipation—Metformin—metabolic syndrome X	0.0097	0.0102	CcSEcCtD
Levobupivacaine—Feeling abnormal—Metformin—metabolic syndrome X	0.00935	0.00986	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00928	0.00978	CcSEcCtD
Levobupivacaine—Urticaria—Metformin—metabolic syndrome X	0.00902	0.0095	CcSEcCtD
Levobupivacaine—Abdominal pain—Metformin—metabolic syndrome X	0.00897	0.00946	CcSEcCtD
Levobupivacaine—Asthenia—Metformin—metabolic syndrome X	0.00814	0.00858	CcSEcCtD
Levobupivacaine—Pruritus—Metformin—metabolic syndrome X	0.00803	0.00846	CcSEcCtD
Levobupivacaine—Diarrhoea—Metformin—metabolic syndrome X	0.00776	0.00818	CcSEcCtD
Levobupivacaine—Dizziness—Metformin—metabolic syndrome X	0.0075	0.00791	CcSEcCtD
Levobupivacaine—Vomiting—Metformin—metabolic syndrome X	0.00722	0.00761	CcSEcCtD
Levobupivacaine—Headache—Metformin—metabolic syndrome X	0.00711	0.00749	CcSEcCtD
Levobupivacaine—Nausea—Metformin—metabolic syndrome X	0.00674	0.0071	CcSEcCtD
Levobupivacaine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—EPHX2—metabolic syndrome X	0.00433	0.0846	CbGpPWpGaD
Levobupivacaine—CYP3A4—Liver X Receptor Pathway—NR1H3—metabolic syndrome X	0.00289	0.0565	CbGpPWpGaD
Levobupivacaine—CYP3A4—Liver X Receptor Pathway—SCD—metabolic syndrome X	0.00256	0.0499	CbGpPWpGaD
Levobupivacaine—CYP1A2—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.00224	0.0438	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.00173	0.0338	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.00141	0.0275	CbGpPWpGaD
Levobupivacaine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.00139	0.0271	CbGpPWpGaD
Levobupivacaine—CYP3A4—Liver X Receptor Pathway—SREBF1—metabolic syndrome X	0.00128	0.0251	CbGpPWpGaD
Levobupivacaine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.00127	0.0248	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—FGF21—metabolic syndrome X	0.0012	0.0234	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.00109	0.0212	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.00103	0.0201	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—EPHX2—metabolic syndrome X	0.000999	0.0195	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.000943	0.0184	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.000835	0.0163	CbGpPWpGaD
Levobupivacaine—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.000835	0.0163	CbGpPWpGaD
Levobupivacaine—CYP1A2—Estrogen Receptor Pathway—PPARA—metabolic syndrome X	0.00081	0.0158	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.000796	0.0155	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.000785	0.0153	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.000728	0.0142	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—FABP4—metabolic syndrome X	0.000715	0.014	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—FABP4—metabolic syndrome X	0.000689	0.0135	CbGpPWpGaD
Levobupivacaine—CYP3A4—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.000645	0.0126	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.000606	0.0118	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—HDAC3—metabolic syndrome X	0.000589	0.0115	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—HDAC3—metabolic syndrome X	0.000568	0.0111	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.000542	0.0106	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—GCK—metabolic syndrome X	0.000458	0.00894	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—GCK—metabolic syndrome X	0.000441	0.00862	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.000418	0.00816	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—FMO3—metabolic syndrome X	0.000417	0.00815	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—FMO3—metabolic syndrome X	0.000411	0.00804	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—SREBF1—metabolic syndrome X	0.00041	0.00802	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—APOE—metabolic syndrome X	0.000405	0.0079	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—SREBF1—metabolic syndrome X	0.000396	0.00773	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—GGT1—metabolic syndrome X	0.000385	0.00753	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—ADIPOQ—metabolic syndrome X	0.000377	0.00736	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.000375	0.00733	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.000367	0.00716	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—ADIPOQ—metabolic syndrome X	0.000363	0.0071	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—SLC2A4—metabolic syndrome X	0.000356	0.00695	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—SLC2A4—metabolic syndrome X	0.000343	0.0067	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—LPL—metabolic syndrome X	0.000334	0.00652	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	0.000322	0.00629	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	0.000318	0.00621	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	0.000318	0.0062	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—metabolic syndrome X	0.000317	0.00619	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00031	0.00606	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00029	0.00566	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.000283	0.00553	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—LPL—metabolic syndrome X	0.000279	0.00546	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—LPL—metabolic syndrome X	0.000269	0.00526	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—CD36—metabolic syndrome X	0.000265	0.00518	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—CD36—metabolic syndrome X	0.000256	0.005	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—PPARA—metabolic syndrome X	0.000247	0.00482	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—GGT1—metabolic syndrome X	0.000245	0.00479	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.000239	0.00468	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—PPARA—metabolic syndrome X	0.000238	0.00465	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—LEP—metabolic syndrome X	0.000234	0.00457	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—LEP—metabolic syndrome X	0.000226	0.00441	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—PPARG—metabolic syndrome X	0.000204	0.00398	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—INS—metabolic syndrome X	0.0002	0.00391	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—PPARG—metabolic syndrome X	0.000197	0.00384	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—INS—metabolic syndrome X	0.000193	0.00377	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—metabolic syndrome X	0.000192	0.00374	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.000179	0.0035	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GGT1—metabolic syndrome X	0.000143	0.0028	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000143	0.00279	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—metabolic syndrome X	0.000139	0.00271	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—metabolic syndrome X	0.000129	0.00253	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—metabolic syndrome X	0.000129	0.00253	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—IL6—metabolic syndrome X	0.000122	0.00239	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—IL6—metabolic syndrome X	0.000118	0.00231	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—TGFB1—metabolic syndrome X	0.000116	0.00227	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.000114	0.00223	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TGFB1—metabolic syndrome X	0.000112	0.00218	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.000111	0.00216	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—TNF—metabolic syndrome X	0.000108	0.00212	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.000108	0.00211	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TNF—metabolic syndrome X	0.000104	0.00204	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	9.41e-05	0.00184	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	9.2e-05	0.0018	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	8.91e-05	0.00174	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	8.82e-05	0.00172	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—IL6—metabolic syndrome X	8.74e-05	0.00171	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—IL6—metabolic syndrome X	8.43e-05	0.00165	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	8.2e-05	0.0016	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—AKT1—metabolic syndrome X	8.06e-05	0.00157	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—AKT1—metabolic syndrome X	7.77e-05	0.00152	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	7.31e-05	0.00143	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	7.26e-05	0.00142	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—FMO3—metabolic syndrome X	7.13e-05	0.00139	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	7.05e-05	0.00138	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	6.75e-05	0.00132	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	6.56e-05	0.00128	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	6.38e-05	0.00125	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MLXIPL—metabolic syndrome X	6.36e-05	0.00124	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—EPHX2—metabolic syndrome X	6.36e-05	0.00124	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—G6PC2—metabolic syndrome X	5.98e-05	0.00117	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	5.68e-05	0.00111	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—FMO3—metabolic syndrome X	5.51e-05	0.00108	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	5.51e-05	0.00108	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—FABP4—metabolic syndrome X	5.08e-05	0.000993	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	4.91e-05	0.000959	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	4.91e-05	0.000959	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	4.82e-05	0.000942	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	4.67e-05	0.000913	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	4.61e-05	0.000901	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	4.54e-05	0.000888	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	4.46e-05	0.000871	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—G6PD—metabolic syndrome X	4.3e-05	0.000839	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	4.24e-05	0.000828	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	4.19e-05	0.000819	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GCKR—metabolic syndrome X	4.1e-05	0.000801	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LPA—metabolic syndrome X	4.1e-05	0.000801	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	3.97e-05	0.000775	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	3.94e-05	0.00077	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOA5—metabolic syndrome X	3.93e-05	0.000768	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—FABP4—metabolic syndrome X	3.92e-05	0.000766	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	3.82e-05	0.000746	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	3.74e-05	0.00073	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	3.72e-05	0.000727	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	3.7e-05	0.000722	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	3.65e-05	0.000714	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—G6PD—metabolic syndrome X	3.32e-05	0.000648	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	3.28e-05	0.00064	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	3.26e-05	0.000636	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LIPC—metabolic syndrome X	3.26e-05	0.000636	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GCK—metabolic syndrome X	3.26e-05	0.000636	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	3.24e-05	0.000632	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOC3—metabolic syndrome X	3.24e-05	0.000632	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GCKR—metabolic syndrome X	3.16e-05	0.000618	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LPA—metabolic syndrome X	3.16e-05	0.000618	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CETP—metabolic syndrome X	3.14e-05	0.000614	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	3.06e-05	0.000598	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOA5—metabolic syndrome X	3.03e-05	0.000592	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	3.01e-05	0.000588	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	2.93e-05	0.000572	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	2.92e-05	0.00057	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	2.84e-05	0.000555	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GOT2—metabolic syndrome X	2.84e-05	0.000555	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	2.82e-05	0.000551	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	2.56e-05	0.000501	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	2.53e-05	0.000495	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	2.53e-05	0.000495	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	2.53e-05	0.000494	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LIPC—metabolic syndrome X	2.51e-05	0.000491	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GCK—metabolic syndrome X	2.51e-05	0.000491	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOC3—metabolic syndrome X	2.5e-05	0.000488	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GGT1—metabolic syndrome X	2.45e-05	0.000479	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GOT1—metabolic syndrome X	2.45e-05	0.000479	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CETP—metabolic syndrome X	2.42e-05	0.000474	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	2.32e-05	0.000453	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	2.25e-05	0.00044	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GOT2—metabolic syndrome X	2.19e-05	0.000428	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	2.19e-05	0.000428	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOB—metabolic syndrome X	2.08e-05	0.000406	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	2.02e-05	0.000395	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LPL—metabolic syndrome X	1.99e-05	0.000388	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.95e-05	0.000382	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.95e-05	0.000382	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.89e-05	0.00037	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.89e-05	0.00037	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CD36—metabolic syndrome X	1.89e-05	0.000369	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARA—metabolic syndrome X	1.75e-05	0.000343	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AGT—metabolic syndrome X	1.7e-05	0.000332	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOE—metabolic syndrome X	1.67e-05	0.000325	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOA1—metabolic syndrome X	1.65e-05	0.000322	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOB—metabolic syndrome X	1.61e-05	0.000314	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	1.56e-05	0.000305	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LPL—metabolic syndrome X	1.53e-05	0.0003	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CD36—metabolic syndrome X	1.46e-05	0.000285	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARG—metabolic syndrome X	1.45e-05	0.000283	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—INS—metabolic syndrome X	1.42e-05	0.000278	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARA—metabolic syndrome X	1.35e-05	0.000265	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AGT—metabolic syndrome X	1.31e-05	0.000256	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALB—metabolic syndrome X	1.3e-05	0.000255	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOE—metabolic syndrome X	1.29e-05	0.000251	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOA1—metabolic syndrome X	1.27e-05	0.000248	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NOS3—metabolic syndrome X	1.25e-05	0.000244	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	1.14e-05	0.000223	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARG—metabolic syndrome X	1.12e-05	0.000219	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—INS—metabolic syndrome X	1.1e-05	0.000214	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALB—metabolic syndrome X	1.01e-05	0.000197	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NOS3—metabolic syndrome X	9.63e-06	0.000188	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	8.81e-06	0.000172	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKT1—metabolic syndrome X	5.73e-06	0.000112	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKT1—metabolic syndrome X	4.43e-06	8.65e-05	CbGpPWpGaD
